Abstract: Lupus miliaris disseminatus faciei is a rare inflammatory dermatosis of unknown etiology that primarily affects young adults. Clinically, it is characterized by an asymptomatic papular eruption mainly involving the central face, typically on and around the eyelids. Characteristic histopathological features include dermal epithelioid cell granulomas with central necrosis and surrounding lymphocytic infiltrate with multinucleate giant cells. Lupus miliaris disseminatus faciei has a spontaneously resolving course, yet can be cosmetically debilitating given the location and potential for scarring. Treatment is difficult and there is a lack of controlled studies. We report a new case of lupus miliaris disseminatus faciei successfully treated with minocycline and systemic steroids, and briefly discuss its nosology and therapeutic options.
INTRODUCTION
Lupus miliaris disseminatus faciei (LMDF), first described by Fox in 1878, is a rare granulomatous inflammatory dermatosis that mostly affects young adults. 1, 2 It is characterized clinically by a bilaterally symmetrical papular eruption located on the central area of the face, and histopathologically by epithelioid cell granulomas with caseous necrosis. 3 Despite the characteristic clinical-pathological features, its etiopathogenesis remains unknown and the treatment is often unsatisfactory.
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CASE REPORT
A previously healthy 43-year-old woman was admitted to our department with an asymptomatic micropapular eruption on the face that had evolved over a period of five months. Physical examination revealed multiple, small (1 to 3 On the basis of these findings, the diagnosis of LMDF was made, and the patient was given oral minocycline 100 mg/day, together with oral prednisolone 5 mg/day. Flattening of the papules was observed within 3 weeks of therapy. By 16 weeks, a moderate improvement had been achieved, despite the residual depressed scars, and minocycline was tapered to 100 mg every other day and prednisolone to 5 mg every other day, which she maintained for an additional eight weeks ( Figure 3 ). No recurrence was noted over a 12-month observation period.
FIGure 1:
Multiple, small, reddish-brown papules scattered over the forehead, eyelids, nose, cheeks, perioral area, and chin Clinically, this dermatosis appears as small, discrete, reddish-yellow or yellowish-brown asymptomatic papules involving primarily the central face, typically on and around the eyelids, although there are some reports of extrafacial involvement. 2, 4 The papules may occur singly or in crops, can be follicular or nonfollicular and, in many cases, show a pustular top. 3 The eruption develops rapidly, running a chronic course, and usually involutes spontaneously within 12 to 24 months, often leaving small pitted scars. The exact etiopathogenesis of LMDF remains unknown.
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Originally it was thought to be a tuberculid, but studies have failed to demonstrate Mycobacterium tuberculosis in LMDF lesions, and this theory is no longer accepted. 3, 4 In the 1980s, many authors considered LMDF to be a variant of granulomatous rosacea, but there are many aspects that differentiate the two diseases, such as the self-limited course with scarring, equal gender distribution, caseation necrosis in the histology, as well as an absence of erythema, flushing, and telangiectasia. 4, 9, 10 Prevention of scarring may be possible with early intervention, using low dose corticosteroids. 3 The successful management of LMDF scars has been reported using a combination of 100% trichloroacetic acid and carbon dioxide lasers. 8 q
